Education
About Us
Working with TipRanks
Follow Us
SUNWELS Co.,Ltd. (JP:9229)
:9229
Top Page
SUNWELS Co.,Ltd.
(9229)
Rating:49Neutral
Price Target:
¥596.00
▼(-0.67%Downside)
SUNWELS Co.,Ltd. (9229) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥22.29B
Dividend Yield2.84%
Average Volume (3M)264.73K
Price to Earnings (P/E)159.7
Beta (1Y)0.92
Revenue Growth29.51%
EPS Growth-175.29%
CountryJP
Employees2,435
SectorHealthcare
Sector Strength40
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)-25.23
Shares Outstanding35,220,000
10 Day Avg. Volume168,060
30 Day Avg. Volume264,733
Financial Highlights & Ratios
PEG Ratio-0.64
Price to Book (P/B)2.03
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥636.00Price Target Upside6.00% Upside
Rating ConsensusHold
Number of Analyst Covering1
SUNWELS Co.,Ltd. Business Overview & Revenue Model
Company Descriptionnull
How the Company Makes Moneynull
SUNWELS Co.,Ltd. Financial Statement Overview
Summary
Income Statement
Balance Sheet
Cash Flow
| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 26.33B | 21.36B | 13.72B | 8.42B | 5.40B | 4.38B |
| Gross Profit | 6.38B | 6.42B | 3.75B | 2.11B | 1.38B | 1.23B |
| EBITDA | 2.37B | 4.35B | 1.93B | 819.00M | 562.83M | 405.01M |
| Net Income | 454.00M | 2.03B | 784.00M | 255.71M | 241.42M | 148.00M |
Balance Sheet | ||||||
| Total Assets | 40.45B | 31.52B | 19.21B | 9.02B | 4.79B | 3.47B |
| Cash, Cash Equivalents and Short-Term Investments | 6.59B | 3.31B | 2.61B | 814.76M | 496.36M | 1.35B |
| Total Debt | 22.82B | 20.11B | 11.20B | 6.60B | 3.03B | 2.04B |
| Total Liabilities | 31.03B | 24.38B | 13.84B | 8.15B | 4.09B | 2.98B |
| Stockholders Equity | 9.42B | 7.14B | 5.37B | 864.74M | 693.47M | 487.00M |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -2.94B | -741.00M | -78.18M | -392.99M | -209.21M |
| Operating Cash Flow | 0.00 | 2.56B | 1.14B | 378.19M | 201.03M | 313.13M |
| Investing Cash Flow | 0.00 | -5.66B | -2.04B | -633.05M | -648.06M | -551.00M |
| Financing Cash Flow | 0.00 | 3.80B | 2.70B | 573.26M | 489.42M | -818.72M |
SUNWELS Co.,Ltd. Technical Analysis
Positive
600.00
Price Trends
572.22
Positive
579.00
Positive
846.11
Negative
Market Momentum
5.79
Positive
56.91
Neutral
44.33
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:9229, the sentiment is Positive. The current price of 600 is below the 20-day moving average (MA) of 603.10, above the 50-day MA of 572.22, and below the 200-day MA of 846.11, indicating a neutral trend. The MACD of 5.79 indicates Positive momentum. The RSI at 56.91 is Neutral, neither overbought nor oversold. The STOCH value of 44.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:9229.
SUNWELS Co.,Ltd. Peers Comparison
Overall Rating
UnderperformOutperform
Sector (46)
Financial Indicators
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥18.98B | 12.47 | 3.95% | 4.15% | -25.67% | ||
68 Neutral | ¥8.77B | 20.08 | ― | 10.60% | 15.70% | ||
66 Neutral | ¥9.80B | 13.31 | 1.49% | 20.50% | 62.39% | ||
63 Neutral | ¥5.95B | 2.91 | 3.25% | 0.91% | 856.87% | ||
63 Neutral | ¥8.78B | 15.87 | 1.44% | 21.97% | -20.94% | ||
49 Neutral | ¥22.29B | 159.73 | 2.84% | 29.51% | -175.29% | ||
46 Neutral | C$198.48M | -3.49 | -23.22% | 2.62% | 21.07% | -1.26% |
* Healthcare Sector Average
Performance Comparison
JP:9229
SUNWELS Co.,Ltd.
633.00
-1,795.31
-73.93%
JP:2374
Saint-Care Holding Corp.
752.00
-79.86
-9.60%
JP:6059
Uchiyama Holdings Co., Ltd.
309.00
-26.76
-7.97%
JP:6557
AIAI Group Corporation
1,326.00
803.50
153.78%
JP:7061
Japan Hospice Holdings Inc.
1,032.00
-380.49
-26.94%
JP:7133
HYUGA PRIMARY CARE Co.,Ltd.
1,351.00
-253.94
-15.82%
SUNWELS Co.,Ltd. Corporate Events
Sunwels Co., Ltd. Announces FY March 2025 Financial Highlights and Healthcare Initiatives
May 15, 2025
Sunwels Co., Ltd. is focusing on addressing societal challenges in healthcare and caregiving by establishing specialized facilities like the ‘PD House’ for Parkinson’s disease, aiming for a sustainable society. The company announced its financial highlights for the fiscal year ending March 2025, emphasizing its commitment to healthcare innovation and sustainability, which may enhance its industry positioning and stakeholder value.
SUNWELS Co.,Ltd. Reports Increased Sales but Declining Profits for FY 2025
May 15, 2025
SUNWELS Co.,Ltd. reported its non-consolidated financial results for the year ending March 31, 2025, showing a significant increase in net sales by 31.8% to 26,496 million yen. However, the company faced a substantial decline in profitability, with operating profit falling by 51.0% and ordinary profit decreasing by 77.4%, resulting in a net loss of 925 million yen. The financial results indicate challenges in maintaining profitability despite increased sales, and the company has decided not to issue dividends for the year. This financial performance could impact its market positioning and stakeholder confidence.
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.